Sign Out
Active immunisation against hepatitis A, Active immunisation against hepatitis B
Adult: Available preparation:
Each 1 mL inj contains hepatitis A virus (inactivated) 720 ELISA U and recombinant hepatitis B surface antigen 20 mcg. Primary immunisation: 1 mL for 3 doses given at 0-, 1-, and 6-months. Alternatively, in exceptional circumstances, an accelerated dose of 1 mL for 3 doses, may be given on days 0, 7, and 21 followed by a booster at 12 months. May be given via SC administration in patients with bleeding disorders.
Child: Available preparations:
Each 0.5 mL inj contains hepatitis A virus (inactivated) 360 ELISA U and recombinant hepatitis B surface antigen 10 mcg
1-15 years Primary immunisation: 0.5 mL for 3 doses, given at 0, 1, and 6 months; ≥16 years Same as adult dose. May be given via SC administration in patients with bleeding disorders.
Each 1 mL inj contains hepatitis A virus (inactivated) 720 ELISA U and recombinant hepatitis B surface antigen 20 mcg.
1-15 years Primary immunisation: 1 mL for 2 doses given at 0 and between 6-12 months; ≥16 years Same as adult dose. May be given via SC administration in patients with bleeding disorders.
Each 1 mL inj contains hepatitis A virus (inactivated) 720 ELISA U and recombinant hepatitis B surface antigen 20 mcg. Primary immunisation: 1 mL for 3 doses given at 0-, 1-, and 6-months. Alternatively, in exceptional circumstances, an accelerated dose of 1 mL for 3 doses, may be given on days 0, 7, and 21 followed by a booster at 12 months. May be given via SC administration in patients with bleeding disorders.
Child: Available preparations:
Each 0.5 mL inj contains hepatitis A virus (inactivated) 360 ELISA U and recombinant hepatitis B surface antigen 10 mcg
1-15 years Primary immunisation: 0.5 mL for 3 doses, given at 0, 1, and 6 months; ≥16 years Same as adult dose. May be given via SC administration in patients with bleeding disorders.
Each 1 mL inj contains hepatitis A virus (inactivated) 720 ELISA U and recombinant hepatitis B surface antigen 20 mcg.
1-15 years Primary immunisation: 1 mL for 2 doses given at 0 and between 6-12 months; ≥16 years Same as adult dose. May be given via SC administration in patients with bleeding disorders.
